Elevated plasma matrix metalloproteinases associate with Mycobacterium tuberculosis blood stream infection and mortality in HIV-associated tuberculosis.
Naomi F WalkerC SchutzA WardD BarrC OpondoM SheyP T ElkingtonK A WilkinsonR J WilkinsonG MeintjesPublished in: medRxiv : the preprint server for health sciences (2023)
Mortality from HIV-associated tuberculosis (HIV-TB) is high, particularly among hospitalised patients. In 433 people living with HIV admitted to hospital with symptoms of TB, we investigated plasma matrix metalloproteinases (MMP) and matrix-derived biomarkers in relation to TB diagnosis, mortality and Mycobacterium tuberculosis ( Mtb) blood stream infection (BSI). Compared to other diagnoses, MMP-8 was elevated in confirmed TB and in Mtb -BSI, positively correlating with extracellular matrix breakdown products. Baseline MMP-3, -7, -8, -10 and procollagen III N-terminal propeptide (PIIINP) associated with Mtb -BSI and 12-week mortality. These findings implicate MMP dysregulation in pathophysiology of advanced HIV-TB and support MMP inhibition as a host-directed therapeutic strategy for HIV-TB.
Keyphrases
- mycobacterium tuberculosis
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- pulmonary tuberculosis
- human immunodeficiency virus
- hiv aids
- hepatitis c virus
- men who have sex with men
- cardiovascular events
- extracellular matrix
- risk factors
- cell migration
- south africa
- healthcare
- coronary artery disease
- ejection fraction
- newly diagnosed
- cardiovascular disease
- emergency department
- depressive symptoms
- randomized controlled trial
- electronic health record
- adverse drug
- double blind
- high speed